ҳ

Laboratory of molecular materials

Gruppbild på Molekylära material

We are a multidisciplinary team with a passion for science. Our research is focused on design and development of molecules, soft materials and hybrid nanoscale components and devices for a wide range of biomedical applications, including diagnostics, biosensors, drug delivery and regenerative medicine.

Our research spans from very fundamental studies of new and innovative soft materials and devices, including novel design, synthesis and fabrication strategies, to exploration of their properties and applications in biomedicine and biotechnology. We have a large interest in molecular self-assembly. In addition to study fundamental self-assembly processes, we utilise self-assembly to create bioresposive and biointeractive materials with defined composition and nanostructure.

We are also actively engaging in collaborations with the health care sector and industry partners. Please contact us for more information!

The Laboratory of Molecular Materials (m2lab) is a unit at the Division of Biophysics and bioengineering at Linköping University.

Lab in Brief

Founded in 2011

Daniel Aili started m2lab as a multidiscplinary research team, both doing fundamental research and collaborating with health care and industry to use lab-results for innovation. 

Research

Peptide-lipid interactions

Numerous peptides interact more or less specifically with lipid membranes. Membrane active peptides are an integral part of the first line of host defence against infections in a wide variety of organisms and can show broad-spectrum antimicrobial activity. The interaction between antimicrobial peptides (APMs) and bacterial lipid membranes leads to loss in membrane integrity, either by formation of transmembrane pores or by a surface-associated carpet mechanism, and there are hence no obvious mechanisms for development of resistance. We study both natural AMPs and designed AMP-mimetic peptides for various therapeutic applications.

Biosensors

By combining our expertise in molecular self-assembly and surface chemistry with innovative transduction technologies, we develop new strategies for biomolecular interaction analysis. In particular we exploit colloidal gold nanoparticles in various sizes and shapes for nanoplasmonic detection of disease biomarkers, protein drugs and toxins. Using designed peptide-based synthetic receptors, robust and sensitive detection can be achieved.

Biomaterials

Biomaterials are materials that are designed to function when in contact with biological systems. In our research we combine different de novo designed peptides with both synthetic polymers and biopolymers, including bacterial cellulose, collagen, hyaluronic acid, and polyethylene glycol, for fabrication of innovative soft biomaterials.

By exploiting biorthogonal covalent crosslinking reactions and self-assembling peptides we are currently developing novel peptide-hybrid materials for applications in 3D cell culture, biomineralization, drug delivery and regenerative medicine. Furthermore, we also combine different fibrous polymer meshes with other functional components (e.g. electrically conducting- and antimicrobial polymers) to realise biomaterials for cardiac regeneration and advanced wound care applications.


Peptides and self-assembly

Polypeptides are ideal components in molecular materials and devices as they can comprise the same chemical and structural diversity as proteins while being very robust. In addition, peptides can provide a multitude of highly specific inter- and intramolecular interactions. These interactions do we in turn try to tailor in order to tune folding and oligomerization as a mean to control the self-assembly of higher order architectures.

Bioengineering human oral tissues and disease models

Emulate & understand: two faces of one coin. In our team, we strive to understand how tissue-resident cells, extracellular matrices, innervation, vasculature and immune cells cooperate and modulate each other’s responses to ensure organ-level functions and topographies. We use this information to create complex, complete 3D models of human organs and diseases. At the same time, we exploit these tools to advance our understanding of tissue development, homeostasis, and the onset of diseases. Our current focus is on the emulation of human dental tissues, human oral cancers, and the human trigeminal complex.

News 

Publications

2026

Johanna Hultman, Vivian Morad, Eliane Tanner, Tristan M. G. Kenney, Zuzanna Pietras, Lalit Pramod Khare, Dean Derbyshire, Diana Resetca, Cheryl H. Arrowsmith, Daniel Aili, Simon Ekstrom, Linda Z. Penn, Björn Wallner, Alexandra Ahlner, Maria Sunnerhagen (2026) Nature Communications, Vol. 17, Article 2016 (Article in journal)
Elisa Zattarin, Wasihun Bekele Kebede, Zeljana Sotra, Rozalin Shamasha, Annika Starkenberg, Valentina Guerrero Florez, Lalit Pramod Khare, Torbjorn Bengtsson, Hazem Khalaf, Emma Björk, Jonathan Rakar, Johan Junker, Daniel Aili (2026) Bioactive Materials, Vol. 61, p. 150-171 (Article in journal)
Wasihun Bekele Kebede, Elisa Zattarin, Zeljana Sotra, Emanuel Wiman, Annika Starkenberg, Sneha Kollenchery Ramanathan, Jonathan Rakar, Tsige Gebre-Mariam, Tesfaye Sisay Tessema, Marten Skog, Petter Sivler, Torbjorn Bengtsson, Hazem Khalaf, Johan Junker, Daniel Aili (2026) ACS Applied Nano Materials, Vol. 9, p. 1571-1583 (Article in journal)

Group members

Organization